Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Broadbent AJ, Subbarao K.

Curr Opin Virol. 2011 Oct;1(4):254-62. doi: 10.1016/j.coviro.2011.08.002. Review.

2.

Pandemic influenza A (H1N1) 2009 vaccination in children: a UK perspective.

de Whalley PC, Pollard AJ.

J Paediatr Child Health. 2013 Mar;49(3):E183-8. doi: 10.1111/jpc.12037. Epub 2012 Dec 16. Review.

PMID:
23253033
3.

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.

Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R.

Influenza Other Respir Viruses. 2011 Sep;5(5):299-305. doi: 10.1111/j.1750-2659.2011.00229.x. Epub 2011 Mar 21. Review.

4.

Influenza vaccine immunology.

Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, Del Giudice G, Rappuoli R.

Immunol Rev. 2011 Jan;239(1):167-77. doi: 10.1111/j.1600-065X.2010.00974.x. Review.

PMID:
21198671
5.

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.

Ahmed SS, Schur PH, MacDonald NE, Steinman L.

J Autoimmun. 2014 May;50:1-11. doi: 10.1016/j.jaut.2014.01.033. Epub 2014 Feb 19. Review.

6.

Safety of pandemic H1N1 vaccines in children and adolescents.

Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.

Vaccine. 2011 Oct 6;29(43):7559-71. doi: 10.1016/j.vaccine.2011.08.016. Epub 2011 Aug 5. Review.

PMID:
21821086
7.

Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.

López-Macías C.

Hum Vaccin Immunother. 2012 Mar;8(3):411-4. doi: 10.4161/hv.18757. Epub 2012 Feb 14. Review.

8.

[Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].

Hara M, Ohfuji S, Fukushima W, Hirota Y.

Nihon Eiseigaku Zasshi. 2013;68(3):153-60. Review. Japanese.

9.

Cross-reactive humoral responses to influenza and their implications for a universal vaccine.

Chiu C, Wrammert J, Li GM, McCausland M, Wilson PC, Ahmed R.

Ann N Y Acad Sci. 2013 Apr;1283:13-21. doi: 10.1111/nyas.12012. Epub 2013 Feb 13. Review.

PMID:
23405860
10.

Recombinant hemagglutinin influenza vaccine provides broader spectrum protection.

Dunkle LM, Izikson R.

Expert Rev Vaccines. 2016 Aug;15(8):957-66. doi: 10.1080/14760584.2016.1203261. Epub 2016 Jul 4. Review.

PMID:
27314982
11.

Towards a sane and rational approach to management of Influenza H1N1 2009.

Gallaher WR.

Virol J. 2009 May 7;6:51. doi: 10.1186/1743-422X-6-51. Review.

12.

Emergence and pandemic potential of swine-origin H1N1 influenza virus.

Neumann G, Noda T, Kawaoka Y.

Nature. 2009 Jun 18;459(7249):931-9. doi: 10.1038/nature08157. Review.

13.

Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.

Pasquini-Descomps H, Brender N, Maradan D.

Value Health. 2017 Jun;20(6):819-827. doi: 10.1016/j.jval.2016.05.005. Epub 2016 Jun 29. Review.

PMID:
28577700
14.

[Guillain-Barré syndrome after exposure to influenza].

Hartung HP, Keller-Stanislawski B, Hughes RA, Lehmann HC.

Nervenarzt. 2012 Jun;83(6):714-30. doi: 10.1007/s00115-012-3479-8. Review. German.

PMID:
22528062
15.

The first influenza pandemic of the 21st century.

Al Hajjar S, McIntosh K.

Ann Saudi Med. 2010 Jan-Feb;30(1):1-10. doi: 10.4103/0256-4947.59365. Review.

16.

The 1918 influenza pandemic: lessons for 2009 and the future.

Morens DM, Taubenberger JK, Harvey HA, Memoli MJ.

Crit Care Med. 2010 Apr;38(4 Suppl):e10-20. doi: 10.1097/CCM.0b013e3181ceb25b. Review.

17.

The prospects and challenges of universal vaccines for influenza.

Subbarao K, Matsuoka Y.

Trends Microbiol. 2013 Jul;21(7):350-8. doi: 10.1016/j.tim.2013.04.003. Epub 2013 May 17. Review.

18.

Reflections on pandemic (H1N1) 2009 and the international response.

Leung GM, Nicoll A.

PLoS Med. 2010 Oct 5;7(10). pii: e1000346. doi: 10.1371/journal.pmed.1000346. Review. No abstract available.

19.

Advances in novel influenza vaccines: a patent review.

Song JM.

J Microbiol. 2016 Jun;54(6):403-12. doi: 10.1007/s12275-016-6176-7. Epub 2016 May 27. Review.

PMID:
27225456
20.

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Jiang S, Li R, Du L, Liu S.

Protein Cell. 2010 Apr;1(4):342-54. doi: 10.1007/s13238-010-0054-6. Epub 2010 May 8. Review.

Supplemental Content

Support Center